Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Amygdala Neurosciences initiates phase Ib study of ALDH2 inhibitor

Aug. 2, 2017

Emergent BioSolutions' development of auto-injector for nerve agent antidote gets financial support

Aug. 1, 2017

FDA grants priority review to RBP-6000 NDA, clearance for buprenorphine assay

Aug. 1, 2017

Pfizer discloses dopamine D3 receptor ligands

July 28, 2017

Opiant reports phase I data on OPNT-002

July 21, 2017

Rolling NDA submission completed for CAM-2038 to treat opioid use disorder

July 20, 2017

MMRF selects Avista Pharma to manufacture component of opioid addiction vaccine

July 14, 2017

FDA grants orphan drug designation to ResQ's LipidRescue

June 16, 2017

Fennec launches European Named Patient Program for sodium thiosulfate

May 31, 2017

Selecta initiates phase I trial of nicotine vaccine candidate SELA-070

May 15, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...